| Literature DB >> 26604432 |
Min He1, Eduard van Wijk1, Ruud Berger2, Mei Wang3, Katrin Strassburg2, Johannes C Schoeman2, Rob J Vreeken4, Herman van Wietmarschen5, Amy C Harms2, Masaki Kobayashi6, Thomas Hankemeier1, Jan van der Greef5.
Abstract
Oxylipins play important roles in various biological processes and are considered as mediators of inflammation for a wide range of diseases such as rheumatoid arthritis (RA). The purpose of this research was to study differences in oxylipin levels between a widely used collagen induced arthritis (CIA) mice model and healthy control (Ctrl) mice. DBA/1J male mice (age: 6-7 weeks) were selected and randomly divided into two groups, namely, a CIA and a Ctrl group. The CIA mice were injected intraperitoneally (i.p.) with the joint cartilage component collagen type II (CII) and an adjuvant injection of lipopolysaccharide (LPS). Oxylipin metabolites were extracted from plasma for each individual sample using solid phase extraction (SPE) and were detected with high performance liquid chromatography/tandem mass spectrometry (HPLC-ESI-MS/MS), using dynamic multiple reaction monitoring (dMRM). Both univariate and multivariate statistical analyses were applied. The results in univariate Student's t-test revealed 10 significantly up- or downregulated oxylipins in CIA mice, which were supplemented by another 6 additional oxylipins, contributing to group clustering upon multivariate analysis. The dysregulation of these oxylipins revealed the presence of ROS-generated oxylipins and an increase of inflammation in CIA mice. The results also suggested that the collagen induced arthritis might associate with dysregulation of apoptosis, possibly inhibited by activated NF-κB because of insufficient PPAR-γ ligands.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26604432 PMCID: PMC4641941 DOI: 10.1155/2015/543541
Source DB: PubMed Journal: Mediators Inflamm ISSN: 0962-9351 Impact factor: 4.711
List of oxylipins detected in mice plasma, measured by multiple reaction monitoring (precursor ions → product ions) in LC-MS/MS analysis.
| Compounds | MS transitions ( |
| VIP | Regulation | Pathway |
|---|---|---|---|---|---|
|
| |||||
| 9,10-DiHOME | 313.2 → 201.1 | 0.0002 | 1.86 | ↓ | CYP450 |
| 12,13-DiHOME | 313.2 → 183.2 | 0.006 | 1.51 | ↓ | CYP450 |
| 9,10-EpOME | 295.2 → 171.2 | 0.028 | 1.27 | ↓ | CYP450 |
| 12,13-EpOME | 295.2 → 195.2 | 0.096 | 1.00 | ↓ | CYP450 |
| 9-KODE | 293.2 → 185.2 | 0.003 | 1.61 | ↓ | 5-LOX |
| 9,12,13-TriHOME | 329.2 → 211.2 | 0.017 | 1.36 | ↓ | 5-LOX |
| 9,10,13-TriHOME | 329.2 → 171.1 | 0.026 | 1.29 | ↓ | 5-LOX |
| 9-HODE | 295.2 → 171.1 | 0.052 | 1.14 | ↓ | 5-LOX |
| 13-KODE | 293.2 → 113.1 | 0.082 | 1.04 | ↓ | 12/15-LOX |
| 13-HODE | 295.2 → 195.2 | 0.733 | 0.21 | — | 12/15-LOX |
|
| |||||
| 12-HEPE | 317.2 → 179.1 | 0.016 | 1.37 | ↑ | 12/15-LOX |
|
| |||||
| 14-HdoHE | 343.2 → 205.0 | 0.010 | 1.45 | ↑ | ROS |
| 13-HdoHE | 343.2 → 281.0 | 0.012 | 1.42 | ↑ | ROS |
| 10-HdoHE | 343.2 → 153.0 | 0.035 | 1.23 | ↑ | ROS |
| 17-HdoHE | 343.2 → 281.3 | 0.173 | 0.83 | — | 12/15 LOX |
| 19,20-DiHDPA | 361.2 → 273.3 | 0.509 | 0.41 | — | CYP450 |
|
| |||||
|
6-keto-PGF1 | 369.2→ 163.1 | 0.390 | 0.53 | — | COX |
| 8-HETrE | 321.3 → 303.0 | 0.469 | 0.45 | — | 12/15 LOX |
|
| |||||
| 8-HETE | 319.2 → 155.1 | 0.074 | 1.06 | ↑ | 12/15-LOX |
| 12-HETE | 319.2 → 179.2 | 0.116 | 0.95 | ↑ | 12/15 LOX |
| 15-HETE | 319.2 → 219.2 | 0.770 | 0.18 | — | 12/15-LOX |
| 5-HETE | 319.2 → 115.1 | 0.713 | 0.23 | — | 5-LOX |
|
13,14-dihydro-PGF2 | 355.2 → 275.3 | 0.112 | 0.96 | ↑ | COX |
| PGF2 | 353.2 → 193.1 | 0.176 | 0.82 | — | COX |
| 13,14-dihydro-15-keto-PGF2 | 353.2→ 183.1 | 0.618 | 0.31 | — | COX |
| 12S-HHTrE | 279.2 → 179.2 | 0.733 | 0.21 | — | COX |
| TXB2 | 369.2 → 169.1 | 0.900 | 0.08 | — | COX |
| 14,15-DiHETrE | 337.2 → 207.2 | 0.662 | 0.27 | — | CYP450 |
| 9-HETE | 319.2 → 167.1 | 0.408 | 0.51 | — | ROS |
| 11-HETE | 319.2 → 167.1 | 0.820 | 0.14247 | — | ROS |
The oxylipins are grouped based on the original polyunsaturated fatty acid precursor: linoleic acid (LA), eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), dihomo-γ-linolenic acid (DGLA), and arachidonic acid (AA). Their metabolic pathways include enzymatic pathways: cyclooxygenase (COX), lipoxygenase (LOX), cytochrome P450 (P450), and nonenzymatic reactive oxygen species (ROS) pathway. The significance of changes between two groups was illustrated by p value from univariate test (Student's t-test) and VIP score from multivariate test (PLS-DA). The important regulations in the CIA group were marked with “↓” or “↑” selected based on VIP scores.
↓: downregulated in CIA group.
↑: upregulated in CIA group.
Figure 1PCA plot of oxylipin data in study mice plasma. PCA score plot of plasma oxylipin data from all study samples revealed general clusters in CIA mice samples and Ctrl samples. The individual samples were marked with “△” or “+” to show the group (CIA versus Ctrl) clustering.
Figure 2Changes in metabolite levels between Ctrl and CIA mice. Individual metabolite levels for the two groups are illustrated using box-plots with the whisker drawn, after logarithmic transformation for normalization. Boxplot colored: white box: metabolites in Ctrl group; grey box: metabolites in CIA group. The metabolites which differed significantly based on Student's t-test (p < 0.05) are marked with “∗”.
Figure 3Overview of regulations of oxylipins in CIA mice compared with Ctrl, including metabolic pathways. Metabolites detected in mice plasma are grouped by metabolic pathways. Important metabolites which contribute most to group clustering based on PLS-DA are colored: yellow box: upregulated in the CIA group; blue box: downregulated in the CIA group.
Figure 4A systematic autoimmune activation in RA. Appearance of proinflammatory cytokines (IL-1β and IL-6, TNFα) as well as the appearance of ROS in RA. The cytokines normally induce the apoptosis via the caspase pathway but also inhibit apoptosis through degradation IκB activating nuclear factor-κB (NF-κB), which consequently translocate to the nucleus upregulating the antiapoptotic genes (BcL2 and BcL-xL). The activated NF-κB then can also further enhance the production of proinflammatory cytokines and chemokines as well as COX-II enzyme. (b) Upregulated oxylipin response. During RA increased levels of AA derived prostaglandins and HETEs are detected. 8- and 12-HETE are able to activate NF-κB exasperating RA. Due to increased levels of ROS, DHA derived peroxidation products are also found. (c) Dysregulated anti-inflammatory response. LA derived oxylipins including HODEs, KODEs, TriHOMEs, DiHOMEs, and EpOMEs are ligands of peroxisome proliferator-activated receptor- (PPAR-) γ. Due to decreased levels of these anti-inflammatory oxylipins, the ability of PPAR-γ to inhibit the activation of NF-κB and indirectly affect apoptosis is diminished.